Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase EARLY_PHASE1 2Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 13Withdrawn 4Terminated 4Unknown 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1Sezary Syndrome 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Adenomatous Polyposis Coli 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × Curcumin × Clear all
NCT04294836 2022-12-07

Curcumin in Advanced Cervical Cancer

Instituto Nacional de Cancerologia, Columbia

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT00248053 2012-09-20

Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients

Johns Hopkins University

Phase 2 Withdrawn
Gastrointestinal

Adenomatous Polyposis Coli

NCT00969085 2012-09-07

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

M.D. Anderson Cancer Center

Phase 2 Withdrawn
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT01269203 2012-09-07

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡